These studies describe an interesting phenomenon: high levels of obestatin in T2D may imply the emergence of diabetic nephropathy [108], as an indicator of increased cardiovascular risk, while high levels of obestatin in patients undergoing chronic hemodialysis may reflect enhanced survivability and CVD-related mortality [106]. This evidence concerns the gene GHRL and diabetic kidney disease.